Effects of the combined PDL/Nd:YAG laser on surgical scars: vascularity and collagen changes evaluated by in vivo confocal microscopy by Vas, Krisztina et al.
Clinical Study
Effects of the Combined PDL/Nd:YAG Laser on
Surgical Scars: Vascularity and Collagen Changes Evaluated by
In Vivo Confocal Microscopy
Krisztina Vas,1 Magdolna Gaál,1 Erika Varga,1 Réka Kovács,1 Balázs Bende,1
Ádám Kocsis,1 and Lajos Kemény1,2
1 Department of Dermatology and Allergology Clinic, University of Szeged, Kora´nyi Fasor 6, Szeged 6720, Hungary
2MTA-SZTE Dermatological Research Group, Kora´nyi Fasor 6, Szeged 6720, Hungary
Correspondence should be addressed to Krisztina Vas; krisztina.vas@mail.derma.szote.u-szeged.hu
Received 16 April 2014; Accepted 3 August 2014; Published 9 September 2014
Academic Editor: Piero Campolmi
Copyright © 2014 Krisztina Vas et al. This is an open access article distributed under the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
The aim of this study was to investigate the efficacy of the sequential combined 585 nm PDL and the 1064 nm neodymium:yttrium-
aluminium-garnet laser (PDL/Nd:YAG) in the treatment of surgical scars and to evaluate the short-term effects by in vivo confocal
microscopy (RCM) and the long-term effects by clinical assessment of the scars. Twenty-five patients were enrolled with 39
postoperative linear scars; each scarwas divided into twofields.One half was treatedwith the combinedPDL/Nd:YAG laser, whereas
the other half remained untreated. Each scar was treated three times at monthly intervals. Scars were evaluated by an independent
examiner, using the Vancouver Scar Scale. The combined PDL/Nd:YAG laser significantly improved the appearance of the scars.
In order to study the short-term effects of combined laser treatment, six additional patients were enrolled with 7 postoperative
linear scars. One half of scars was treated once with the combined PDL/Nd:YAG laser. One week after this laser treatment, both
the treated and the nontreated parts of the scars were examined by dermoscopy and RCM. The dermoscopic pictures revealed
improvements even in treated areas. In conclusion, the combined PDL/Nd:YAG laser was found to be effective in improving the
quality and appearance of the surgical scars.
1. Introduction
Despite modern suturing techniques, operations may be
followed by the development of nonesthetic scars. Surgical
scars often remain red in color, firm, and elevated to the
touch. Some scars may persist in a hyperpigmented form or
may become hypertrophic or keloid. These nonesthetic scars
may come to be regarded as permanent stigmas and often
cause considerable esthetic and psychological problems for
patients. Various therapeutic modalities have been attempted
with the aim of improving the clinical appearance of scars,
with differing degrees of success, for example, corticosteroid
injection, dermabrasion, surgical revision, chemical peeling,
silicone gel application, vitamin E-based remedies, pressure
therapy and X-ray irradiation, cryosurgery, 5-fluorouracil
(a pyrimidine analog), and certain antitumor agents (e.g.,
Bleomycin) [1–6].
Lasers have also been applied to improve the appearance
of such scars. The first lasers utilized for this purpose
were ablative, nonselective lasers: carbon dioxide (CO
2
) or
erbium:yttrium-aluminium-garnet (Er:YAG) laser [7–11].
Nouri et al. recently studied the use of the pulsed dye laser
(PDL) at differentwavelengths (585 nmand 595 nm) andwith
different pulse durations (short and long), and Conologue
and Norwood demonstrated that the cryogen-cooled 595 nm
PDL treatment is effective in improving the wound healing
[12–15].
Investigations of the therapeutic efficacy of different laser
and light source combinations (e.g., the combination of
the PDL and the Nd:YAG laser) are important in view of their
complementary nature. The skin contains a number of light-
absorbing substances (chromophores) such as water, mela-
nin, hemoglobin, and exogenous pigments. An initial low
PDLpulse selectively increases the local blood temperature to
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Table 1: Patients’ data: 25 participants between the ages of 17 and 50 years with Fitzpatrick skin types I–IV and linear scars greater than 3 cm
were enrolled into the study.
Patient Sex Age (years) Scars (number of pieces) Fitzpatrick skin types Location
1 F 40 1 II. Abdomen
2 F 20 1 III. Scapula
3 F 35 1 II. Abdomen
4 F 26 2 II. Back
5 M 25 3 II. Back
6 M 25 2 III. Neck
7 M 25 1 II. Neck
8 F 39 2 III. Abdomen
9 F 17 1 II. Back
10 F 23 1 I. Waist
11 F 38 1 II. Mons pubis
12 F 23 1 I. Abdomen
13 F 24 1 II. Leg
14 F 27 1 II. Leg
15 F 30 2 III. Back and arm
16 F 21 1 IV. Back
17 F 30 3 II. Neck, back, and upper arm
18 F 26 2 II. Abdomen
19 F 25 3 II. Abdomen
20 F 50 1 III. Back
21 F 25 1 III. Back
22 F 19 1 II. Back
23 F 19 2 III. Back
24 F 21 2 II. Mons pubis and back
25 F 32 2 II. Back
62–80∘C, resulting in oxyhemoglobin-methemoglobin con-
version. A recent study revealed that the light of the Nd:YAG
laser is preferentially absorbed bymethemoglobin rather than
by oxyhemoglobin. The high temperature attained induces
blood coagulation in the vessels of the treated area. The
combination of these lasers functions via selective pho-
tothermolysis, which targets the blood vessels with minimal
damage to the surrounding tissues.
As sequential combined PDL/Nd:YAG laser treatment
has been shown to be highly effective for the treatment of
acne vulgaris, cutaneous photoaging, and leg veins, the aim of
our present study was to investigate the efficacy of combined
PDL/Nd:YAG laser treatment on the appearance of scars,
when used immediately after suture removal [16–18].
In this study, treatment was performed on regular scars
after surgery starting right after the removal of sutures. Our
results conclude that combined PDL/Nd:YAG laser therapy
starting on the day of suture removal is safe and effective in
improving the quality and cosmetic appearance of surgical
scars in patients with skin types I–IV; the improvement
was confirmed at structural level by dermoscopy, in vivo
confocal microscopy, and VSS. RCM permits the real-time
imaging of human skin including various skin disorders. It
is a noninvasive high-resolution imaging technique which
allows the structural and cellular visualization and analysis of
the skin to a depth up to 250 𝜇m.This technique can be used
in a wide range of dermatological settings. Objective data can
be obtained on the skin structure and its alterations in various
conditions. It is also widely used to evaluate almost any kind
of superficial skin lesions. The RCM assist of the diagnosis
and differential diagnosis of skin diseases can be refined and
a more specific opinion can be provided without or before
a surgical biopsy. It can help in the assessment of lesions
with a clinical and dermoscopic suspicion of malignancy
eliminating the performance of unnecessary surgical biopsies
or confirming a previous diagnosis in order to plan the
optimal surgical solution [19–21].
2. Methods
2.1. Effects of the Combined PDL/Nd:YAG Laser on the
Clinical Appearance of the Scars. Twenty-five (22 female
and 3 male) participants between the age of 17 and 50
years, with Fitzpatrick skin types I–IV and linear scars
greater than 3 cm originating from nevus removal, were
enrolled into the study (Table 1). The patients had been
operated on at the Plastic Surgery Unit of the Department
of Dermatology and Allergology Clinic in Szeged. All of the
patients involved in the study had otherwise healthy skin and
were not suffering from major medical illnesses. Exclusion
criteria were pregnancy, lactation, medicines that increase
sensitivity to light, anticoagulant medication, a history of
malignancy, and susceptibility to keloids and hypertrophic
wound healing. All surgical procedures had been carried out
by the same group of plastic surgeons, and wound closure
had been performed with standardized suturing techniques
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(two-layer intracutaneous running, one deeper absorbable
suture and one superficial nonabsorbable suture).The sutures
were removed 14 days after the operation.
The patient’s informed consent was obtained in all cases
before laser treatment was started immediately after suture
removal, followed by repeat treatments 4 and 8 weeks later.
Twenty-five patients with 39 postoperative linear scars
were treated three times at monthly intervals with the
combined 585 nm PDL and 1064 nmNd:YAG laser (Cynergy,
Cynosure Inc., Westford, MA, USA).
Each scar was divided into two fields; one half of each scar
was treated with the combined PDL/Nd:YAG laser and the
other half remained untreated. The treated and the control
halves were selected randomly.
The 585 nm PDL was used with a spot size of 10mm with
10% overlap and a pulse duration of 0.5ms at a fluence of
4.5 J/cm2, in combination with treatment with the 1064 nm
Nd:YAG laser with a spot size of 10mm and a pulse duration
of 15ms at a fluence of 60 J/cm2, with 500ms time delay
between the delivery of the two wavelengths. Specific safety
eyeglasses were worn during the treatment. The skin surface
was cooled with a continuous flow of cold air. The patients
reported only minimal pain during treatment; erythema
appeared around the scar 1-2 days after the laser treatment.
No serious side-effects of the treatment were observed. All
photographs were taken by one photographer with a Nikon
D200 camera, under identical conditions of illumination and
patient positioning. Analysis was performed on 39 scars in a
blind study by an independent examiner one month after the
last treatment (third laser irradiation).
The level of improvement of the scars was evaluated by
using the Vancouver Scar Scale (VSS) one month after the
final treatment. This scale is the internationally accepted
method for the description of scars. The VSS consists of
four variables: vascularity, height (thickness), pliability, and
pigmentation. Each variable has four to six possible scores. A
total score ranges from 0 to 13, where the score of 0 reflects
normal skin.
Statistical analysis was performed with the SPSS 15.0
software.
The Wilcoxon test chosen for the evaluation allows
determination of the degree of improvement based on the
VSS (pigmentation, vascularity, pliability, and height) scores
of the scars in both the treated and the untreated parts.
2.2. Effects of the Combined PDL/Nd:YAG Laser Treatment
on Blood Vessels and on Collagen Fibers. To determine the
effects of the combined PDL/Nd:YAG laser therapy on scar
microcirculation, dermoscopy and in vivo confocal micro-
scopic analyses were performed.
Half of each scar in 6 patients (5 female and 1 male) with
7 postoperative linear scars was treated immediately after
suture removal once with the combined PDL/Nd:YAG laser,
and, one week later, both parts of the scar were examined
by dermoscopy and reflectance-mode in vivo confocal
microscopy (RCM).
One week after the combined laser treatment, the der-
moscopic and RCM images of the 7 scars of the 6 patients
were analyzed with the LUCID VivaScope 1500 Multilaser
(MAVIG GmbH, Munich, Germany) equipment, using the
785 nmwavelength laser of the machine. Our objectives were
to analyze the microcirculation and the structures of the
epidermis and collagen bundles and to assess the differences
between the treated and untreated areas. Images were made
first of the combined PDL/Nd:YAG laser-treated and then
of the control areas. The captured areas also contained the
neighboring normal skin. The first step was to obtain a
dermoscopic picture of the examined area with the RCM
machine camera.The zero level was then determined and this
level was marked relative to the surface of the scar tissue.
The first image was intended to be taken at the level of
the stratum granulosum-spinosum.We captured the stratum
corneumof the scar as the zero level and then defined the first
level which was usually 25–30𝜇m deeper than the zero one.
Three further images were next obtained, each 25𝜇m deeper
than the previous one. Due to the above mentioned surface
irregularity, we often had to make an additional fifth layer to
visualize the deeper structures appropriately. The maximum
area of 8 × 8mm was captured at each level. We also made
two Vivastack captures at representative parts of the scar and
a comparative one at the normal skin area. These Vivastack
images were taken from the level of the stratum granulosum-
spinosum down to 150𝜇m in 1.5-𝜇m steps. Vessels were
detected and compared on the basis of the dermoscopy and
RCM images.
3. Results
3.1. Effects of the Combined PDL/Nd:YAG Laser on the Clinical
Appearance of the Scars. The combined PDL/Nd:YAG laser
treatment resulted in a significant clinical improvement of the
scars (Figures 1 and 2). The surgical scar is depicted from the
day of suture removal to the final combined laser treatment.
Onemonth after the third combined laser treatment, the final
analysis revealed a significant difference in favor of the treated
parts of the scar.
The VSS parameters (𝑛 = 39 scars) demonstrated a
significant dermoscopic improvement relative to the con-
trol (Figure 3). A worsening status of wound healing after
laser treatment was detected only in one patient, where we
observed pink vascularity, hyperpigmentation, supple, and 2–
5mm heightened parts of the scar at the treated region.
Each of the four parameters (pigmentation, vascularity,
pliability, and height) was improved significantly 1 month
after the final combined laser treatment (Figure 4). There
were no significant complications during this study. Both
patients and doctors were satisfied with the cosmetic appear-
ance of the surgical scars after final combined laser therapy.
Three months after the last laser treatment, further improve-
ment in the clinical appearance of the laser treated scars was
observed (not shown).
3.2. Effects of the Combined PDL/Nd:YAG Laser Treatment on
Blood Vessels and on Collagen Fibers. Concerning each of the
investigated parameters, the combined PDL/Nd:YAG laser
significantly improved the appearance of the scars; thus, we
set out to enroll further 6 subjects in order to study the short-
term effect of combined laser treatment.









Figure 1: Effects of combined 585/1064 nm laser treatment on the clinical appearance of the scar back of in the patient number 16 (Fitzpatrick
skin type IV) on the day of suture removal (a), 1 month after the first treatment (b), 1 month after the second treatment (c), and at the final









Figure 2: Effects of combined 585/1064 nm laser treatment on the clinical appearance of the scar waist of in the patient number 10 (Fitzpatrick
skin types I) on the day of suture removal (a), 1 month after the first treatment (b), 1 month after the second treatment (c), and at the final
assessment (d). The treated half (Treated) and the control half (Control) of the scar are indicated.














Figure 3: VSS score 1 month after final treatment and final


















Figure 4: Improvement in individual VSS parameters 1 month after
the final combined PDL/Nd:YAG laser treatment (𝑛 = 25); ∗𝑃 <
0.05 was regarded as a significant change.
One week after the combined PDL/Nd:YAG laser treat-
ment, the dermoscopic pictures of the control, untreated area
displayed marked parallel or lace-like vascularity (Figure 5),
which was pronounced not only in the scar area but also
around it. In several cases, the scar appeared to be slightly
elevated; however, more often a depressed characteristic was
detectable.
The epidermis exhibited a regular or broadened honey-
comb pattern according to the RCM investigation, although
some areas revealed atypical keratinocytes as well. The der-
moepidermal junction showed nonspecific pattern without
papillary contours. Parallel, rough, coarse collagen bundles
were detected in the upper dermis, whereas the vessels were
dilated and horizontal.
The treated area of the dermoscopic pictures revealed a
narrower scar with notably decreased vascularity. The vessels
were more delicate and situated apparently haphazardly
compared to the untreated part. The treated scars were
usually depressed. In some cases, the surroundings of the
scar displayed more vascularity than the scar itself. The
epidermis also had a broadened honeycomb pattern with
a low number of atypical keratinocytes and some dendritic
inflammatory cells. At the dermoepidermal junction, the
pattern was nonspecific, without papillary contours similar
to the untreated area. The collagen fibers were comparably
coarse; however, they were not numerous and their orienta-
tion was not uniformly parallel. Only low numbers of narrow
horizontal vessels were observed.
4. Discussion
Different techniques are used to enhance wound healing,
but, thanks to the rapid advances in laser technology, a new
method has emerged with a promising future for modern
wound healing.
The flashlamp-pumped PDL, which emits light at a
wavelength of 585 nm, has become the gold standard in the
treatment of port-wine stains and also an effective treatment
modality for superficial vascular lesions, including those
associated with photoaging, such as facial telangiectasias.
The Nd:YAG laser emits light at a wavelength of 1064 nm,
which allows deep penetration into the dermis and vascular
specificity due to a broad absorption peak of oxyhemoglobin
above 800 nm [17, 18].
PDL and Nd:YAG lasers of different wavelengths have
been incorporated in the novel dual laser device built into
the same console. Laser and light source combinations are
currently being examined for their complementary, additive,
or sometimes synergistic action.
The abnormal blood vessels in the scar tissue area are
occluded and absorbed, which results in artificial ischemia,
inhibiting nutrient supply to the wound. The laser treatment
enhances wound contraction, the remodelling of collagen
fibers by thermal necrosis, activation of the release of basic
fibroblast growth factor, and inhibition of transforming
growth factor 𝛽1 [1, 2]. The combined laser therapy addi-
tionally decreases the accumulation of fibroblast cells in
the scar tissue and stimulates the production of reticular
collagen fibers [10, 11]. Treatment with the combined 585 nm
PDL and 1064 nm Nd:YAG laser is noninvasive, minimally
uncomfortable, and requires no anesthesia.
Jung et al. compared a PDL and a combinedPDL/Nd:YAG
laser in the treatment of acne vulgaris and found that the
combined PDL/Nd:YAG laser was significantly better than
the PDL in reducing noninflammatory acne lesion counts 8
weeks after the treatment; an improvement was also observed
in the treatment of inflammatory acne lesions, though it
was not statistically significant [16]. Trelles et al. described
the efficiency of the PDL/Nd:YAG laser combination in the
treatment of leg veins [18]. Berlin et al. treated cutaneous
photoaging symptoms with a combined PDL/Nd:YAG laser.
Their examinations indicated the greatest improvements in
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Figure 5: Effects of a single combined 585/1064 nm laser treatment on the blood vessels and collagen fibers (abdomen). The untreated areas
((a), (b), (c), and (d)) and treated areas ((e), (f), (g), and (h)) are indicated. Control area: the dermatoscopic picture revealed high vascularity
in the scar tissue ((a) Bar = 92.96 𝜇m).The RCM picture of the scar and its surroundings indicated that the scar is only slightly depressed ((b)
Bar = 132.59 𝜇m); there are numerous, parallel collagen fibers with numerous dilated vessels (arrows) among them (c) and numerous parallel
collagen fibers ((d) Bar = 132.59 𝜇m). Treated area: the dermatoscopic picture shows low vascularity in the scar tissue (e). The RCM picture
of the scar and its surroundings demonstrated that the scar is depressed relative to the normal skin ((f) Bar = 70.10𝜇m); there were collagen
fibers regular and elongated and a few narrow vessels (arrows) among them ((g) Bar = 138.68 𝜇m) and regular and elongated collagen fibers
((h) Bar = 129.54 𝜇m).
telangiectasias and diffuse erythema, with slightly less change
in epidermal pigmentation and lentigines. The combined
sequential PDL/Nd:YAG laser can be used safely and effec-
tively in facial photorejuvenation [17].
Nouri et al. compared the effectiveness of the 585 nm
versus the 595 nm PDL in the treatment of new surgical
scars. Both lasers improved the cosmetic appearance of the
scars statistically. However, 585 nm appeared to be the better
wavelength, as it substantially normalized the height in a
significant number of the scars, in addition to the vascularity
and pliability. It also emerged that both short (450 𝜇s) and
long (1.5 ms) 585 nm pulses were safe and effective in
improving the quality and cosmetic appearance of surgical
scars starting on the day of suture removal. No significant
difference was detected between the results with the different
pulse durations.The cryogen-cooled 585 nmand 595 nmPDL
was used with a spot size of 10mm or 7mm and a pulse
duration of 450𝜇s or 1.5ms at a fluence of 3.5 J/cm2 to treat
surgical scars starting on the day of suture removal [12–14].
In previous publications, the most significant improve-
ments were found in vascularity and pliability after therapy
with the 585 nm or 595 nm PDL [12–15].
Bencini et al. have described the long-term effects of
carbon dioxide (CO
2
) laser treatment on skin aging after
fractional laser therapy lasting 6 weeks to 3 months at least.
Epidermal changes and collagen remodeling were evaluated
by in vivo confocal microscopy [22]. Recently, Sattler et al.
treated healthy probandswith fractional carbon dioxide laser;
then the optical follow-ups were performed using confocal
laser scanning microscopy and optical coherence tomogra-
phy right after laser application and during the following
3 weeks. Both of these techniques were able to visualize
the therapeutical effects of the laser therapy, suggesting that
noninvasivemethods could be used to evaluate the efficacy of
laser treatments [23].
The aimof the present studywas to investigate the efficacy
of the combined 585/1064 nm laser treatment of surgical scars
and to evaluate the short-term effects by in vivo confocal
microscopy and the long-term effects by VSS. Surgical scar
treatment with the combined PDL/Nd:YAG laser therapy
starting on the day of suture removal has not been reported
previously.
In our study, one half of each of the postoperative linear
scars immediately after suture removal was treated three
times at monthly intervals with the combined 585/1064 nm
laser and the cosmetic appearances of the treated and
untreated scar halves were compared. The VSS parameters
indicated a significant improvement at the final assessment
relative to the control. Our results are in concordance with
recent data of other authors on the topic.
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When additional surgical scars (𝑛 = 7 scars) were
similarly treated only once with the combined 585/1064 nm
laser, dermatoscopy and RCM one week later demonstrated
an improvement in the treated area, which exhibited only
low numbers of narrow horizontal vessels and decreased
amounts of collagen fibers, the orientations of which were
not uniformly parallel. We examined both parts of the scar
by dermatoscopy and RCM one week later since the high
temperature applied induces occlusion and absorption of
abnormal blood vessels in the scar tissue area, which results
in artificial ischemia, inhibiting nutrient supply to thewound.
We eliminated the subjectivity of the independent examiner;
therefore, the evaluation of changes in vascularisation and
rearrangement of collagen bundles was measured using
RCM.We found that RCMwas suitable for the monitoring of
wound healing with or without the combined 585/1064 nm
laser treatment. In conclusion, the combined PDL/Nd:YAG
laser proved to be safe and effective in improving the cosmetic
appearance (𝑛 = 39 scars) of surgical scars in patients with
skin types I–IV, starting on the day of suture removal, and this
improvement was confirmed at the structural level (𝑛 = 7) by
in vivo confocal microscopy. RCM proved to a valuable tool
for monitoring the efficacy of laser treatment of the scars.
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